Design of 4-substituted sulfonamidobenzoic acid derivatives targeting coxsackievirus b3

HIGHLIGHTS

  • who: Anton A. Shetnev and collaborators from the Pharmaceutical Technology Transfer Center, Yaroslavl State Pedagogical University Named after KDUshinsky, Respublikanskaya St., Yaroslavl, Russia have published the research: Design of 4-Substituted Sulfonamidobenzoic Acid Derivatives Targeting Coxsackievirus B3, in the Journal: Life 2022, 12, x FOR PEER REVIEW of /2022/
  • what: At the beginning of the study , cytoprotection properties of compounds against the pleconaril-resistant strain Coxsackievirus B3 Nancy were determined using a wellknown cytoprotection assay. The authors prepared 15 novel compounds bearing 4-substitutedsulfonyl-)4aminobenzoic acid and their surrogates, which are characterized in antiviral assays . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?